128 related articles for article (PubMed ID: 38335457)
21. Atherosclerotic Peripheral Artery Disease in the United States: Gender and Ethnic Variation in a Multiple Cause-of-Death Analysis.
Nwancha AB; Alvarado E; Ma J; Gillum RF; Hughes K
Vasc Endovascular Surg; 2020 Aug; 54(6):482-486. PubMed ID: 32468924
[TBL] [Abstract][Full Text] [Related]
22. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
[TBL] [Abstract][Full Text] [Related]
23. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
Pulte D; Jansen L; Brenner H
Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
[TBL] [Abstract][Full Text] [Related]
24. Changing causes of death in persons with haematological cancers 1975-2016.
Chen L; Zheng Y; Yu K; Chen S; Wang W; Gale RP; Liu ZX; Liang Y
Leukemia; 2022 Jul; 36(7):1850-1860. PubMed ID: 35577905
[TBL] [Abstract][Full Text] [Related]
25. Using multiple-cause-of-death data as a complement of underlying-cause-of-death data in examining mortality differences in psychiatric disorders between countries.
Lu TH; Lin JJ
Soc Psychiatry Psychiatr Epidemiol; 2010 Aug; 45(8):837-42. PubMed ID: 19727532
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and Predictors of 30-Day Readmission in CAR-T Cell Therapy Recipients.
Sharma A; Singh V; Deol A
Transplant Cell Ther; 2023 Feb; 29(2):108.e1-108.e7. PubMed ID: 36371048
[TBL] [Abstract][Full Text] [Related]
27. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
[TBL] [Abstract][Full Text] [Related]
28. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
Sanchez-Pina JM; Rodríguez Rodriguez M; Castro Quismondo N; Gil Manso R; Colmenares R; Gil Alos D; Paciello ML; Zafra D; Garcia-Sanchez C; Villegas C; Cuellar C; Carreño-Tarragona G; Zamanillo I; Poza M; Iñiguez R; Gutierrez X; Alonso R; Rodríguez A; Folgueira MD; Delgado R; Ferrari JM; Lizasoain M; Aguado JM; Ayala R; Martinez-Lopez J; Calbacho M
Eur J Haematol; 2020 Nov; 105(5):597-607. PubMed ID: 32710500
[TBL] [Abstract][Full Text] [Related]
29. Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia.
Morawska M
Eur J Haematol; 2022 Feb; 108(2):91-98. PubMed ID: 34717004
[TBL] [Abstract][Full Text] [Related]
30. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
García-Suárez J; de la Cruz J; Cedillo Á; Llamas P; Duarte R; Jiménez-Yuste V; Hernández-Rivas JÁ; Gil-Manso R; Kwon M; Sánchez-Godoy P; Martínez-Barranco P; Colás-Lahuerta B; Herrera P; Benito-Parra L; Alegre A; Velasco A; Matilla A; Aláez-Usón MC; Martos-Martínez R; Martínez-Chamorro C; Susana-Quiroz K; Del Campo JF; de la Fuente A; Herráez R; Pascual A; Gómez E; Pérez-Oteyza J; Ruiz E; Alonso A; González-Medina J; Martín-Buitrago LN; Canales M; González-Gascón I; Vicente-Ayuso MC; Valenciano S; Roa MG; Monteliu PE; López-Jiménez J; Escobar CE; Ortiz-Martín J; Diez-Martin JL; Martinez-Lopez J;
J Hematol Oncol; 2020 Oct; 13(1):133. PubMed ID: 33032660
[TBL] [Abstract][Full Text] [Related]
31. Malignant (Diffuse) Mesothelioma in Patients With Hematologic Malignancies: A Clinicopathologic Study of 45 Cases.
Li X; Brownlee NA; Sporn TA; Mahar A; Roggli VL
Arch Pathol Lab Med; 2015 Sep; 139(9):1129-36. PubMed ID: 25844559
[TBL] [Abstract][Full Text] [Related]
32. Parents' ages at birth and risk of adult-onset hematologic malignancies among female teachers in California.
Lu Y; Ma H; Sullivan-Halley J; Henderson KD; Chang ET; Clarke CA; Neuhausen SL; West DW; Bernstein L; Wang SS
Am J Epidemiol; 2010 Jun; 171(12):1262-9. PubMed ID: 20507900
[TBL] [Abstract][Full Text] [Related]
33. Multiple causes of death analysis of chronic diseases: the example of diabetes.
Fedeli U; Zoppini G; Goldoni CA; Avossa F; Mastrangelo G; Saugo M
Popul Health Metr; 2015; 13():21. PubMed ID: 26309427
[TBL] [Abstract][Full Text] [Related]
34. Bendamustine in the treatment of hematologic malignancies. Introduction.
Diehl V; Cheson BD
Semin Oncol; 2002 Aug; 29(4 Suppl 13):1-3. PubMed ID: 12170424
[No Abstract] [Full Text] [Related]
35. COPD-Related Mortality and Co-morbidities in Northeastern Italy, 2008-2012: A Multiple Causes of Death Analysis.
Marcon A; Saugo M; Fedeli U
COPD; 2016; 13(1):35-41. PubMed ID: 26367073
[TBL] [Abstract][Full Text] [Related]
36. The increase of sepsis-related mortality in Italy: a nationwide study, 2003-2015.
Grande E; Grippo F; Frova L; Pantosti A; Pezzotti P; Fedeli U
Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1701-1708. PubMed ID: 31187308
[TBL] [Abstract][Full Text] [Related]
37. B-Cell Malignancies: The Use of Small Molecule Agents for Treatment and Management.
Rogers BB
Clin J Oncol Nurs; 2020 Apr; 24(2):199-204. PubMed ID: 32196006
[TBL] [Abstract][Full Text] [Related]
38. Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death.
Sheu MJ; Liang FW; Lin CY; Lu TH
Popul Health Metr; 2021 Apr; 19(1):22. PubMed ID: 33926463
[TBL] [Abstract][Full Text] [Related]
39. Nationwide analysis of adult hospitalizations with hematologic malignancies and systemic sclerosis.
Romero Noboa ME; Litvin R; Sami F; Tanveer S
ARP Rheumatol; 2023; 2(4):291-298. PubMed ID: 38174748
[TBL] [Abstract][Full Text] [Related]
40. Different approaches to the analysis of causes of death during the COVID-19 epidemic.
Fedeli U; Schievano E; Avossa F; Pitter G; Barbiellini Amidei C; Grande E; Grippo F
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3610-3613. PubMed ID: 34002836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
